ReIGNITE放疗推量:一项前瞻性国际研究评估放射肿瘤科医生单独使用常规磁共振成像或借助限制谱成像勾画前列腺肿瘤用于局灶放疗推量的准确性
这项多机构国际前瞻性研究纳入44名放射肿瘤科医生和2名专家放射科医生,对39例患者病例在常规MRI单独或联合RSIrs图条件下勾画前列腺肿瘤。使用RSIrs图后,完全遗漏至少一个专家定义靶病灶的参与者从44人中的40人(91%)降至44人中的13人(30%),所有勾画准确性指标改善约50%或以上。
要点
- 44名参与者中40人(91%)在无RSIrs时完全遗漏至少一个专家定义靶病灶,有RSIrs时降至13人(30%)。
- 常规MRI单独勾画尝试762次中134次(18%)完全遗漏靶区,联合RSIrs图842次中18次(2%)完全遗漏。
- RSIrs图使所有勾画准确性指标改善约50%或以上,系统可用性评分72对58(p < 0.001)。
核心结论
- 放射肿瘤科医生在常规MRI上准确勾画可见前列腺癌肿瘤存在困难,RSIrs图可提高其针对MRI可见肿瘤进行前列腺肿瘤推量的靶向能力。
研究设计与样本
- 多机构、国际、前瞻性研究,纳入44名放射肿瘤科医生(参与者)和2名专家放射科医生(专家),对39例患者病例进行勾画。
主要发现
- 共产生1604个参与者勾画体积。
- 44名参与者中40名(91%)在无RSIrs时完全遗漏至少1个专家定义靶病灶,而有RSIrs图时为44名中13名(30%)。
- 常规MRI单独勾画尝试762次中134次(18%)完全遗漏靶区,联合RSIrs图842次中18次(2%)完全遗漏。
- 使用RSIrs图使所有勾画准确性指标改善约50%或以上,混合效应模型证实RSIrs图是所有指标改善的主要变量。
- 系统可用性评分显示RSIrs图显著改善勾画体验(72 vs. 58,p < 0.001)。
关键数值与推荐
- 勾画准确性指标包括与专家体积重叠百分比、Dice系数、共形数和超出专家体积的最大距离。
- 系统可用性评分RSIrs图72 vs. 58,p < 0.001。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In a phase III randomized trial, adding a radiation boost to tumor(s) visible on MRI improved prostate cancer (PCa) disease-free and metastasis-free survival without additional toxicity. Radiation oncologists' ability to identify prostate tumors is critical to widely adopting intraprostatic tumor radiotherapy boost for patients. A diffusion MRI biomarker, called the Restriction Spectrum Imaging restriction score (RSIrs), has been shown to improve radiologists' identification of clinically significant PCa. We hypothesized that (1) radiation oncologists would find accurately delineating PCa tumors on conventional MRI challenging and (2) using RSIrs maps would improve radiation oncologists' accuracy for PCa tumor delineation. METHODS AND MATERIALS: In this multi-institutional, international, prospective study, 44 radiation oncologists (participants) and 2 expert radiologists (experts) contoured prostate tumors on 39 total patient cases using conventional MRI with or without RSIrs maps. Participant volumes were compared to the consensus expert volumes. Contouring accuracy metrics included percent overlap with expert volume, Dice coefficient, conformal number, and maximum distance beyond expert volume. RESULTS: 1604 participant volumes were produced. 40 of 44 participants (91%) completely missed ≥1 expert-defined target lesion without RSIrs, compared to 13 of 44 (30%) with RSIrs maps. On conventional MRI alone, 134 of 762 contour attempts (18%) completely missed the target, compared to 18 of 842 (2%) with RSIrs maps. Use of RSIrs maps improved all contour accuracy metrics by approximately 50% or more. Mixed effects modeling confirmed that RSIrs maps were the main variable driving improvement in all metrics. System Usability Scores indicated RSIrs maps significantly improved the contouring experience (72 vs. 58, p < 0.001). CONCLUSIONS: Radiation oncologists struggle with accurately delineating visible PCa tumors on conventional MRI. RSIrs maps improve radiation oncologists' ability to target MRI-visible tumors for prostate tumor boost.
引用
- Lui AJ, Kallis K, Zhong AY, et al. ReIGNITE Radiation Therapy Boost: A Prospective, International Study of Radiation Oncologists' Accuracy in Contouring Prostate Tumors for Focal Radiation Therapy Boost on Conventional Magnetic Resonance Imaging Alone or With Assistance of Restriction Spectrum Imaging. Int J Radiat Oncol Biol Phys. 2023. PMID: 37453559. doi:10.1016/j.ijrobp.2023.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。